We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
-5.27%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$267M
AUM Growth
+$35.7M
Cap. Flow
+$63.8M
Cap. Flow %
23.89%
Top 10 Hldgs %
99.34%
Holding
44
New
27
Increased
4
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
BBRE icon
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
+$48.1M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$10.1M
3
VIR icon
Vir Biotechnology
VIR
+$3.32M
4
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$2.95M
5
XOM icon
ExxonMobil
XOM
+$1M

Top Sells

Rank Stock Value
1
WTTR icon
Select Water Solutions
WTTR
+$2.52M
2
MSFT icon
Microsoft
MSFT
+$11K
3
PEP icon
PepsiCo
PEP
+$1K

Sector Composition

Rank Sector Weight
1 Healthcare 8.21%
2 Technology 2.89%
3 Energy 0.36%
4 Communication Services 0.19%
5 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBRE icon
1
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.25B
$212M 79.54%
2,708,621
+532,990
+24% +$48.1M
EOCW.U
2
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$19.8M 7.4%
2,000,000
– –
KRTX
3
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11.2M 4.2%
+49,788
New +$10.1M
IMTX icon
4
Immatics
IMTX
$1.33B
$6.97M 2.61%
697,431
– –
TXN icon
5
Texas Instruments
TXN
$253B
$4.95M 1.86%
32,000
– –
HCP
6
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$2.76M 1.03%
+85,603
New +$2.95M
VIR icon
7
Vir Biotechnology
VIR
$1.52B
$2.51M 0.94%
+130,409
New +$3.32M
VT icon
8
Vanguard Total World Stock ETF
VT
$81.4B
$2.33M 0.87%
29,585
– –
BOND icon
9
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
$1.39M 0.52%
15,502
– –
XOM icon
10
ExxonMobil
XOM
$657B
$960K 0.36%
+10,993
New +$1M
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$662K 0.25%
847,108
– –
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.19T
$514K 0.19%
5,350
+5,270
+6,588% +$588K
APEN
13
DELISTED
Apollo Endosurgery, Inc.
APEN
$172K 0.06%
31,202
+15,601
+100% +$86.5K
SYRE icon
14
Spyre Therapeutics
SYRE
$9.18B
$129K 0.05%
9,827
– –
TFFP
15
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$90K 0.03%
883
– –
LXRX icon
16
Lexicon Pharmaceuticals
LXRX
$1.05B
$86K 0.03%
35,714
– –
PLXP
17
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$81K 0.03%
125,346
+62,673
+100% +$92.4K
POR icon
18
Portland General Electric
POR
$5.74B
$5K ﹤0.01%
118
– –
TAK icon
19
Takeda Pharmaceutical
TAK
$55.6B
$2K ﹤0.01%
+137
New +$1.91K
ABEV icon
20
Ambev
ABEV
$43.5B
$1K ﹤0.01%
+231
New +$655
AEG icon
21
Aegon
AEG
$13.9B
$1K ﹤0.01%
+136
New +$592
BABA icon
22
Alibaba
BABA
$300B
$1K ﹤0.01%
+8
New +$762
BUD icon
23
AB InBev
BUD
$156B
$1K ﹤0.01%
+13
New +$673
E icon
24
ENI
E
$79.6B
$1K ﹤0.01%
+25
New +$576
ENIC icon
25
Enel Chile
ENIC
$6.05B
$1K ﹤0.01%
+423
New +$628
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2022 Portfolio in Review

As of Q3 2022, University of Texas/Texas AM Investment Management Co (UTIMCO) held 44 positions worth $267M, up 15% from $231M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $63.8M of net new capital in Q3 2022, opening 27 new positions and adding to 4 existing holdings. Its largest new stake was Karuna Therapeutics, Inc. Common Stock: 49,788 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.2% of assets, up from 3.9% a quarter earlier, followed by Technology and Energy.

On the sell side, the most notable exit was Select Water Solutions, an estimated $2.52M sold.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2022 buy was Karuna Therapeutics, Inc. Common Stock: 49,788 shares worth $11.2M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to JPMorgan BetaBuilders MSCI US REIT ETF in Q3 2022, an estimated $48.1M increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Select Water Solutions in Q3 2022, selling an estimated $2.52M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 99% of its $267M portfolio in Q3 2022.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 27 new positions and closed 3 in Q3 2022.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 15% quarter-over-quarter to $267M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2022, filed 14 Nov 2022.